Board of Directors​

Organization and responsibilities of the Board of Directors

The Board of Directors of OBI Pharma, Inc. is composed of six internationally renowned directors in various professional fields such as new drug research and development, biostatistics, law, international trade, accounting, etc., who are not only experienced and educated, but also have an international outlook, a broad vision, and insight into the current situation to ensure the direction and level of the company’s operation. 
Under the leadership of the Chairman, the Board of Directors of OBI Pharma, Inc. takes “integrity and social responsibility” as the core, and is responsible for counseling, supervising and evaluating the effective operation of the company’s management team and various departments. Internally, we strive to comply with laws and regulations and self-examine ourselves with the highest ethical standards, and set up various functional committees and audit offices such as audit and remuneration to implement the internal control system; Seek financial transparency and real-time disclosure of important information to protect the rights and interests of investors and fulfill corporate social responsibility. 

In addition, the external performance evaluation of the Board of Directors is conducted every three years, and the most recent performance evaluation of the Board of Directors was conducted by the China Corporate Governance Association, an external organization, for the period from January 1, 2021 to December 31, 2021. The performance evaluation of the board of directors of the organization is based on eight aspects, including the composition of the board of directors, guidance, delegation, supervision, communication, internal control and risk management, and self-discipline and other aspects of the board of directors. The evaluation method is based on questionnaires and company self-assessment, and the association reviews the relevant documents provided by the Company for review in writing, and interviews the chairman, independent directors and chief financial officer of the Company on February 14, 2022, to assist the Company in improving through the interaction and sharing of the evaluation process. The Board of Directors performance evaluation report was submitted on February 22, 2022, and the Company reported the results of the Board of Directors on March 18, 2022

Communication between independent directors and the head of internal audit and accountants

1. The Company’s internal audit supervisor regularly communicates with the members of the Audit Committee the results of the audit report, and makes an internal audit report at the quarterly Audit Committee meeting, and reports to the members of the Audit Committee immediately if there is any special situation. There were no such special circumstances in the current year. The communication between the Audit Committee and the Head of Internal Audit of the Company is in good condition.
2. The Company’s certified public accountants shall report the results of the audit of the financial statements and other communication matters required by relevant laws and regulations to the Audit Committee on a quarterly basis, and will report to the members of the Audit Committee immediately if there are any special circumstances, and there are no such special circumstances in the current year. The Company’s Audit Committee is in good communication with the certified public Accountants.